Ann: Appendix 4C - Quarterly and Business Update, page-10

Gees I hate that picture on the website. Although Tissue Therapies were worse with the real pictures of ulcerated limbs.

This is all great news for imu, as it's more proof of immunology. Imugene's is extra good, as the patient produces their own antibodies, hence in theory is completely safe and side effect free - and this seems to be true in practice.

Whilst I can always understand people leaving share investing, like MM has, I still think we could easily attract a big pharma deal/takeover. We appear to have the safest effective treatment in the newest big area of cancer treatment. That's a great place to be imho. We have far more promise that Viralytics ever had (where I was also invested) and they got taken over for $500m.